photo collage
  • ECONOMIC VALUE: By helping alleviate the burden of chronic diseases, we're helping alleviate the economic drain of NCDs, which account for 75% of healthcare spending globally and are projected to cause productivity losses of a trillion dollars — in emerging countries alone — by 2015.

    Economic Value
  • CLINICAL OUTCOMES: By putting more focus on chronic disease worldwide, we should start to see improved corrective action and long-term management, which should improve patient outcomes.

    Clinical Outcomes
  • SOCIETAL IMPACT: By working with the NCD Alliance and other industry partners, we can contribute to the World Health Organization's goal of reducing chronic disease death rates by 2% annually through 2015.

    Societal Impact

Taking On
The Global
NCD Challenge

Tackling Noncommunicable Disease

Chronic, noncommunicable diseases (NCDs) — including heart disease and diabetes — are quickly becoming the world's greatest health issue. They already account for more than 60% of all deaths worldwide and are projected to increase 15% by 2020. The social and economic impact they will have on our world in the coming decades will be profound — unless we take action now. That's why we recently introduced our Global NCD Initiative, a long-term strategic commitment to help drive the high-level policy and health system changes needed to reduce the global burden of chronic disease.

A Growing Health And Economic Burden

NCDs: The Leading Cause of Death Worldwide (2011, The NCD Alliance)

Cause of Death chart

NCDs: The Largest Global Healthcare Cost (2011, The NCD Alliance)

Healthcare Cost chart

Our Contributions

video screenshot

Tackling Noncommunicable Disease Video >



Learn more about the Medtronic Global NCD Initiative >



Learn more about the United Nations High-Level Meeting on NCDs >

We're leveraging all our corporate assets — people, products, and philanthropy — to help alleviate the growing challenge and threat of NCDs. Our efforts are focused in three key areas:

open/close
Tackling NCD photo
Herb Riband
Vice President, External Affairs International

Global Policy and Advocacy

We're working with policymakers, healthcare professionals, and nonprofit organizations to elevate the issue of chronic disease prevention and management on a global level. Specific actions include:

  • Support of the NCD Alliance: The Medtronic Foundation contributed $1 million to this coalition — an alliance of nonprofit organizations representing 170 countries — to help develop recommendations for a United Nations High-Level Meeting on noncommunicable diseases.
  • Lead Private Sector Coalition: Through this collection of health-minded global companies, we're helping elevate the issue of chronic disease and align private efforts.
  • Policy and Regulatory Reform: We're driving initiatives to improve patient access to needed treatments and therapies.
 
open/close
Tackling NCD photo

Strengthening Health Systems

We're helping train healthcare professionals and patients, and ensuring NCD care is integrated into primary care systems. Examples include:

  • Beijing Patient Care Center: We opened this hands-on education center in 2010 to help patients better understand the therapies available to them — through discussions with physicians and Medtronic representatives and the aid of 3-D product models.
  • Physician Education: We've invested millions of dollars to educate healthcare professionals on the safe use of our therapies — via 22 education centers in 17 countries, high-fidelity simulators, and video conferencing.
  • Global Health Grants: Medtronic Foundation grants are helping integrate chronic disease management into primary care systems in developing countries, as well as supporting public education efforts to share key knowledge about prevention, diagnosis, and treatment options for chronic disease.
 
open/close
Tackling NCD photo

Therapy & Healthcare Delivery Innovation

We're developing technologies and identifying best practices that can make Medtronic therapies more affordable, appropriate, and accessible throughout the world. Examples include:

  • Local Research and Development: We're expanding technical development and clinical research at the local level to help address the health needs specific to various countries and regions.
  • Breakthrough Technologies: We're developing products that can accommodate mobile and remote delivery of healthcare to make treatments more accessible.
  • Business Model Innovation: We're increasing our capabilities to design, test, and scale new business models in developing countries to make treatments more accessible.
 

Benefit Summary

Through our Global NCD Initiative, we're leveraging Medtronic people, products, and philanthropy in a strategic effort to help address the global issue of chronic, noncommunicable disease.

  • ECONOMIC VALUE: By helping alleviate the burden of chronic diseases, we're helping alleviate the economic drain of NCDs, which account for 75% of healthcare spending globally and are projected to cause productivity losses of a trillion dollars — in emerging countries alone — by 2015.
  • CLINICAL OUTCOMES: By putting more focus on chronic disease worldwide, we should start to see improved corrective action and long-term management, which should improve patient outcomes.
  • SOCIETAL IMPACT: By working with the NCD Alliance and other industry partners, we can contribute to the World Health Organization's goal of reducing chronic disease death rates by 2% annually through 2015.